CIK 0000899923
- Accelerated filer
MYRIAD GENETICS INC
Sign in to watch- Ticker
- MYGN
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 870494517
- Phone
- +1 801-584-3600
- Business address
- 322 NORTH 2200 WEST, SALT LAKE CITY, UT, 84116
- Former names
- MYRIAD GENETICS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2006-11-16 | GILBERT WALTER PHD Director | Grant or award · Non-Qualified Stock Option (right to buy) | +15,000 | 15,000 | ||
| 2006-11-10 | GILBERT WALTER PHD Director | Sale | −9,498 | $26.92 | $256K | 0 |
| 2006-11-10 | GILBERT WALTER PHD Director | Sale | −16,799 | $26.94 | $452K | 0 |
| 2006-11-09 | GILBERT WALTER PHD Director | Sale | −3,472 | $27.14 | $94K | 9,498 |
| 2006-11-09 | GILBERT WALTER PHD Director | Sale | −6,171 | $27.14 | $167K | 16,799 |
| 2006-01-06 | GILBERT WALTER PHD Director | Grant or award · Non-Qualified Stock Option (right to buy) | +15,000 | 15,000 |
Page 1 of 1 · 6 trades